Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Immune Tolerance | 12 | 2017 | 2324 | 1.450 |
Why?
|
Histocompatibility, Maternal-Fetal | 3 | 2018 | 9 | 1.150 |
Why?
|
Histocompatibility Testing | 9 | 2024 | 726 | 1.090 |
Why?
|
Isoantibodies | 6 | 2023 | 681 | 0.990 |
Why?
|
Maternal-Fetal Exchange | 4 | 2018 | 453 | 0.930 |
Why?
|
Graft Rejection | 16 | 2024 | 4499 | 0.750 |
Why?
|
T-Lymphocytes, Regulatory | 7 | 2021 | 3111 | 0.710 |
Why?
|
Placentation | 1 | 2021 | 79 | 0.710 |
Why?
|
HLA Antigens | 8 | 2024 | 1339 | 0.700 |
Why?
|
Receptors, Virus | 2 | 2015 | 651 | 0.690 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2024 | 1365 | 0.680 |
Why?
|
Th17 Cells | 2 | 2015 | 786 | 0.540 |
Why?
|
Transplants | 1 | 2019 | 208 | 0.530 |
Why?
|
Reproduction | 1 | 2021 | 641 | 0.530 |
Why?
|
Kidney Transplantation | 7 | 2024 | 4270 | 0.520 |
Why?
|
Epitopes, B-Lymphocyte | 1 | 2016 | 84 | 0.510 |
Why?
|
Transplantation Tolerance | 2 | 2018 | 640 | 0.490 |
Why?
|
Membrane Glycoproteins | 6 | 2007 | 3690 | 0.470 |
Why?
|
Diabetes Mellitus, Type 1 | 7 | 2014 | 3446 | 0.470 |
Why?
|
Lung Transplantation | 6 | 2024 | 1311 | 0.470 |
Why?
|
Immunity, Maternally-Acquired | 2 | 2021 | 112 | 0.450 |
Why?
|
Placenta | 5 | 2015 | 1728 | 0.440 |
Why?
|
Uterus | 2 | 2015 | 661 | 0.440 |
Why?
|
Stem Cell Transplantation | 2 | 2019 | 1602 | 0.420 |
Why?
|
Peptides | 6 | 2007 | 4331 | 0.420 |
Why?
|
Mice, Inbred CBA | 5 | 2015 | 439 | 0.400 |
Why?
|
Amino Sugars | 1 | 2011 | 39 | 0.390 |
Why?
|
Listeriosis | 3 | 2006 | 146 | 0.380 |
Why?
|
Fetus | 3 | 2015 | 1870 | 0.360 |
Why?
|
Macrophage Colony-Stimulating Factor | 2 | 2001 | 186 | 0.340 |
Why?
|
Heart Transplantation | 8 | 2018 | 3310 | 0.320 |
Why?
|
Dendritic Cells | 8 | 2018 | 2747 | 0.320 |
Why?
|
Organ Transplantation | 1 | 2019 | 1174 | 0.310 |
Why?
|
CD4-Positive T-Lymphocytes | 8 | 2020 | 4405 | 0.300 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 2 | 2011 | 820 | 0.300 |
Why?
|
Immunity, Cellular | 2 | 2017 | 1555 | 0.290 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2011 | 1441 | 0.290 |
Why?
|
Mice, Inbred NOD | 8 | 2020 | 1837 | 0.280 |
Why?
|
Th1 Cells | 5 | 2011 | 1039 | 0.280 |
Why?
|
Antibodies | 4 | 2017 | 2417 | 0.280 |
Why?
|
Pregnancy Complications | 1 | 2021 | 2975 | 0.270 |
Why?
|
Interleukin-17 | 2 | 2020 | 921 | 0.270 |
Why?
|
Tissue Donors | 9 | 2023 | 2395 | 0.270 |
Why?
|
Pregnancy | 11 | 2021 | 30260 | 0.270 |
Why?
|
Immunologic Factors | 3 | 2014 | 1587 | 0.260 |
Why?
|
Mice, Inbred C57BL | 19 | 2018 | 22332 | 0.260 |
Why?
|
Mice | 34 | 2024 | 81819 | 0.260 |
Why?
|
CD8-Positive T-Lymphocytes | 8 | 2024 | 4642 | 0.250 |
Why?
|
Fetal Resorption | 1 | 2005 | 15 | 0.250 |
Why?
|
Polysaccharides | 1 | 2011 | 1016 | 0.240 |
Why?
|
Adoptive Transfer | 3 | 2014 | 827 | 0.240 |
Why?
|
Antibodies, Monoclonal | 7 | 2017 | 9249 | 0.230 |
Why?
|
Physicians | 1 | 2022 | 4588 | 0.220 |
Why?
|
Interleukin-6 | 4 | 2018 | 3222 | 0.220 |
Why?
|
Immunity, Innate | 2 | 2012 | 3081 | 0.210 |
Why?
|
Myocarditis | 1 | 2011 | 802 | 0.210 |
Why?
|
Hypersensitivity, Delayed | 1 | 2024 | 490 | 0.210 |
Why?
|
Animals | 37 | 2024 | 168764 | 0.210 |
Why?
|
Transplantation Immunology | 2 | 2017 | 541 | 0.210 |
Why?
|
Mice, Knockout | 13 | 2018 | 14448 | 0.190 |
Why?
|
Reperfusion Injury | 2 | 2018 | 1042 | 0.180 |
Why?
|
T-Lymphocytes | 7 | 2020 | 10261 | 0.170 |
Why?
|
Mice, Mutant Strains | 2 | 2001 | 1745 | 0.170 |
Why?
|
Autoimmunity | 2 | 2007 | 1354 | 0.170 |
Why?
|
Pregnancy, Animal | 1 | 2000 | 124 | 0.160 |
Why?
|
Viral Matrix Proteins | 1 | 2020 | 192 | 0.160 |
Why?
|
Antigens | 2 | 2023 | 1438 | 0.160 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 62 | 0.160 |
Why?
|
Signal Transduction | 8 | 2018 | 23601 | 0.160 |
Why?
|
Graft vs Host Disease | 2 | 2023 | 3078 | 0.160 |
Why?
|
Isoantigens | 3 | 2017 | 562 | 0.160 |
Why?
|
Antigens, Surface | 3 | 2008 | 1617 | 0.160 |
Why?
|
Alleles | 2 | 2023 | 6897 | 0.160 |
Why?
|
Skin | 2 | 2024 | 4489 | 0.150 |
Why?
|
Trophoblasts | 1 | 2000 | 223 | 0.150 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2018 | 89 | 0.150 |
Why?
|
Graft Survival | 8 | 2018 | 3890 | 0.150 |
Why?
|
Apoptosis Regulatory Proteins | 3 | 2008 | 1151 | 0.150 |
Why?
|
Killer Cells, Natural | 2 | 2018 | 2210 | 0.140 |
Why?
|
T-Lymphocytes, Cytotoxic | 2 | 2024 | 1801 | 0.140 |
Why?
|
Immunomodulation | 1 | 2021 | 547 | 0.140 |
Why?
|
Immunomagnetic Separation | 1 | 2016 | 78 | 0.130 |
Why?
|
Models, Immunological | 1 | 2018 | 517 | 0.130 |
Why?
|
Histocompatibility | 1 | 2017 | 327 | 0.130 |
Why?
|
Autoantibodies | 1 | 2024 | 2113 | 0.130 |
Why?
|
Medical Tourism | 1 | 2016 | 51 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 825 | 0.120 |
Why?
|
Female | 31 | 2024 | 396112 | 0.120 |
Why?
|
Lymph Nodes | 3 | 2018 | 3454 | 0.120 |
Why?
|
Bronchiolitis Obliterans | 1 | 2017 | 221 | 0.120 |
Why?
|
Mice, Inbred BALB C | 9 | 2018 | 6220 | 0.120 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 1 | 2016 | 304 | 0.120 |
Why?
|
Chemokines | 2 | 2015 | 956 | 0.120 |
Why?
|
Herpesvirus 4, Human | 1 | 2020 | 1078 | 0.120 |
Why?
|
Cells, Cultured | 9 | 2020 | 18973 | 0.120 |
Why?
|
Macrophages | 2 | 2018 | 5772 | 0.120 |
Why?
|
Pregnancy Outcome | 2 | 2021 | 2966 | 0.120 |
Why?
|
Th2 Cells | 4 | 2011 | 1075 | 0.120 |
Why?
|
Cross Reactions | 1 | 2016 | 824 | 0.110 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2018 | 478 | 0.110 |
Why?
|
Interleukin-15 | 1 | 2015 | 186 | 0.110 |
Why?
|
Antigens, Neoplasm | 2 | 2020 | 2002 | 0.110 |
Why?
|
Interferon-gamma | 5 | 2020 | 3160 | 0.110 |
Why?
|
Drug Carriers | 1 | 2018 | 700 | 0.110 |
Why?
|
Antigens, Ly | 1 | 2015 | 296 | 0.110 |
Why?
|
Kidney | 3 | 2023 | 7066 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2023 | 5753 | 0.110 |
Why?
|
Receptors, Antigen, T-Cell | 2 | 2023 | 2570 | 0.110 |
Why?
|
Litter Size | 1 | 2013 | 49 | 0.110 |
Why?
|
B-Lymphocytes | 3 | 2020 | 4778 | 0.110 |
Why?
|
Embryo Loss | 1 | 2013 | 55 | 0.110 |
Why?
|
Vaccines, Synthetic | 1 | 1996 | 621 | 0.110 |
Why?
|
Spleen | 3 | 2018 | 2296 | 0.110 |
Why?
|
Mice, Transgenic | 5 | 2018 | 9550 | 0.100 |
Why?
|
BCG Vaccine | 1 | 1996 | 380 | 0.100 |
Why?
|
Flow Cytometry | 4 | 2013 | 5881 | 0.100 |
Why?
|
Vaccines, Inactivated | 1 | 1993 | 185 | 0.100 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2013 | 120 | 0.100 |
Why?
|
Glomerulonephritis | 1 | 2014 | 332 | 0.100 |
Why?
|
Skin Diseases | 1 | 2020 | 1088 | 0.100 |
Why?
|
Kidney Glomerulus | 1 | 2014 | 568 | 0.090 |
Why?
|
Lectins, C-Type | 1 | 2015 | 592 | 0.090 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2015 | 891 | 0.090 |
Why?
|
Neutrophils | 2 | 2001 | 3776 | 0.090 |
Why?
|
Antibody Specificity | 1 | 2013 | 1061 | 0.090 |
Why?
|
Fibrosis | 1 | 2018 | 2070 | 0.090 |
Why?
|
Trachea | 1 | 2017 | 1085 | 0.090 |
Why?
|
Immunotherapy | 2 | 2019 | 4752 | 0.090 |
Why?
|
Humans | 33 | 2024 | 765968 | 0.090 |
Why?
|
Cell Movement | 3 | 2018 | 5194 | 0.090 |
Why?
|
Biological Assay | 1 | 2013 | 627 | 0.090 |
Why?
|
Microspheres | 1 | 2013 | 773 | 0.090 |
Why?
|
Cytokines | 6 | 2018 | 7421 | 0.090 |
Why?
|
Immunophenotyping | 1 | 2015 | 1866 | 0.090 |
Why?
|
Telomere | 1 | 2016 | 943 | 0.090 |
Why?
|
Gene Knock-In Techniques | 1 | 2011 | 419 | 0.080 |
Why?
|
Surgical Sponges | 1 | 2009 | 40 | 0.080 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 2 | 2008 | 305 | 0.080 |
Why?
|
Transplantation, Homologous | 6 | 2018 | 4860 | 0.080 |
Why?
|
Lymphocyte Activation | 5 | 2019 | 5501 | 0.080 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1996 | 838 | 0.080 |
Why?
|
Nanoparticles | 2 | 2018 | 1964 | 0.080 |
Why?
|
Cell Adhesion Molecules | 1 | 2015 | 1612 | 0.080 |
Why?
|
Coculture Techniques | 1 | 2012 | 1336 | 0.080 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 919 | 0.080 |
Why?
|
Interleukin-1beta | 1 | 2014 | 1028 | 0.070 |
Why?
|
Spinal Cord | 1 | 2016 | 1784 | 0.070 |
Why?
|
Observer Variation | 1 | 2013 | 2615 | 0.070 |
Why?
|
Lung Diseases | 1 | 2017 | 1940 | 0.070 |
Why?
|
Male | 21 | 2024 | 363698 | 0.070 |
Why?
|
Peptide Fragments | 1 | 2019 | 5125 | 0.070 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2009 | 290 | 0.070 |
Why?
|
Vascular Patency | 1 | 2009 | 912 | 0.070 |
Why?
|
Graft Occlusion, Vascular | 1 | 2009 | 540 | 0.070 |
Why?
|
Mycobacterium tuberculosis | 2 | 1996 | 1917 | 0.060 |
Why?
|
Disease Models, Animal | 4 | 2018 | 18293 | 0.060 |
Why?
|
Mice, SCID | 3 | 2020 | 2630 | 0.060 |
Why?
|
Acute Kidney Injury | 1 | 2018 | 1946 | 0.060 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2207 | 0.060 |
Why?
|
Receptors, Cell Surface | 1 | 2015 | 2817 | 0.060 |
Why?
|
Lymphocyte Depletion | 1 | 2007 | 605 | 0.060 |
Why?
|
Cell Separation | 1 | 2011 | 1718 | 0.060 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2007 | 894 | 0.060 |
Why?
|
Lymphocytes | 1 | 2013 | 2599 | 0.060 |
Why?
|
T-Lymphocyte Subsets | 1 | 2013 | 1811 | 0.060 |
Why?
|
Fathers | 1 | 2007 | 376 | 0.060 |
Why?
|
Endothelial Cells | 2 | 2024 | 3584 | 0.060 |
Why?
|
Upper Extremity | 1 | 2009 | 682 | 0.060 |
Why?
|
Forkhead Transcription Factors | 2 | 2008 | 1624 | 0.060 |
Why?
|
Receptor, Angiotensin, Type 1 | 1 | 2024 | 153 | 0.050 |
Why?
|
Melanoma | 2 | 2019 | 5719 | 0.050 |
Why?
|
Ultrasonography | 1 | 2017 | 5993 | 0.050 |
Why?
|
Tissue Scaffolds | 1 | 2009 | 934 | 0.050 |
Why?
|
Homeodomain Proteins | 2 | 2018 | 2428 | 0.050 |
Why?
|
Nitric Oxide | 1 | 2011 | 2143 | 0.050 |
Why?
|
Gene Expression Regulation | 3 | 2018 | 11888 | 0.050 |
Why?
|
Prediabetic State | 1 | 2008 | 548 | 0.050 |
Why?
|
Islets of Langerhans Transplantation | 1 | 2007 | 746 | 0.050 |
Why?
|
Heart Diseases | 1 | 2015 | 2821 | 0.050 |
Why?
|
Treatment Outcome | 7 | 2019 | 65188 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4427 | 0.050 |
Why?
|
Blood Group Incompatibility | 1 | 2023 | 134 | 0.050 |
Why?
|
Abortion, Spontaneous | 1 | 2007 | 536 | 0.050 |
Why?
|
Stevens-Johnson Syndrome | 1 | 2024 | 231 | 0.050 |
Why?
|
Neoplasms | 3 | 2020 | 22340 | 0.050 |
Why?
|
Microscopy, Electron | 2 | 2015 | 2548 | 0.050 |
Why?
|
Drug Eruptions | 1 | 2024 | 335 | 0.050 |
Why?
|
Islets of Langerhans | 1 | 2007 | 1349 | 0.050 |
Why?
|
OX40 Ligand | 1 | 2020 | 57 | 0.040 |
Why?
|
Tuberculosis | 1 | 1993 | 2012 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2020 | 4260 | 0.040 |
Why?
|
ABO Blood-Group System | 1 | 2023 | 380 | 0.040 |
Why?
|
Renal Dialysis | 1 | 2009 | 1799 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2019 | 5849 | 0.040 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2009 | 1434 | 0.040 |
Why?
|
Clone Cells | 1 | 2023 | 1672 | 0.040 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2019 | 126 | 0.040 |
Why?
|
Lymphotoxin beta Receptor | 1 | 2018 | 26 | 0.040 |
Why?
|
Cell Line | 1 | 2012 | 15543 | 0.040 |
Why?
|
Lymphotoxin-alpha | 1 | 2018 | 94 | 0.040 |
Why?
|
Adult | 12 | 2024 | 223044 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2015 | 7851 | 0.040 |
Why?
|
Living Donors | 1 | 2023 | 645 | 0.040 |
Why?
|
Transplantation, Heterotopic | 1 | 2018 | 175 | 0.040 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2000 | 657 | 0.030 |
Why?
|
Abscess | 1 | 2001 | 606 | 0.030 |
Why?
|
Middle Aged | 11 | 2024 | 223009 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 2 | 2014 | 18071 | 0.030 |
Why?
|
Antigen-Presenting Cells | 1 | 2020 | 962 | 0.030 |
Why?
|
Jurkat Cells | 1 | 2018 | 737 | 0.030 |
Why?
|
Apoptosis | 1 | 2012 | 9514 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2019 | 13648 | 0.030 |
Why?
|
Homozygote | 1 | 2001 | 1775 | 0.030 |
Why?
|
ROC Curve | 2 | 2014 | 3620 | 0.030 |
Why?
|
Coronary Artery Disease | 1 | 2015 | 6544 | 0.030 |
Why?
|
Paraplegia | 1 | 2016 | 158 | 0.030 |
Why?
|
Mycobacterium bovis | 1 | 1996 | 148 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2023 | 2729 | 0.030 |
Why?
|
Aged | 9 | 2024 | 171117 | 0.030 |
Why?
|
Immunoglobulins | 1 | 2018 | 852 | 0.030 |
Why?
|
Immunity, Humoral | 1 | 2019 | 605 | 0.030 |
Why?
|
Leprostatic Agents | 1 | 1994 | 14 | 0.030 |
Why?
|
Nephritis | 1 | 2015 | 146 | 0.030 |
Why?
|
Leprosy, Lepromatous | 1 | 1994 | 23 | 0.030 |
Why?
|
Heterozygote | 1 | 2001 | 2794 | 0.030 |
Why?
|
Endothelin-1 | 1 | 2015 | 295 | 0.030 |
Why?
|
Phenotype | 1 | 2011 | 16721 | 0.030 |
Why?
|
Up-Regulation | 2 | 2017 | 4137 | 0.030 |
Why?
|
Mutagenesis, Insertional | 1 | 1996 | 661 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2020 | 17075 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 2018 | 4165 | 0.030 |
Why?
|
Biopsy | 2 | 2015 | 6763 | 0.030 |
Why?
|
Prospective Studies | 4 | 2020 | 54802 | 0.030 |
Why?
|
Insulin | 1 | 2006 | 6599 | 0.020 |
Why?
|
Bacterial Vaccines | 1 | 1994 | 400 | 0.020 |
Why?
|
Safety | 1 | 1996 | 1157 | 0.020 |
Why?
|
Cancer Vaccines | 1 | 2018 | 1044 | 0.020 |
Why?
|
Immunosuppressive Agents | 2 | 2018 | 4209 | 0.020 |
Why?
|
Quality Control | 1 | 2013 | 837 | 0.020 |
Why?
|
Immunocompetence | 1 | 2010 | 138 | 0.020 |
Why?
|
Neoplasms, Experimental | 1 | 2015 | 1229 | 0.020 |
Why?
|
Receptors, Interleukin-8A | 1 | 2009 | 47 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2019 | 10429 | 0.020 |
Why?
|
Mice, Inbred DBA | 1 | 2010 | 623 | 0.020 |
Why?
|
Genes, MHC Class II | 1 | 2009 | 433 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4562 | 0.020 |
Why?
|
Genotype | 1 | 2023 | 13024 | 0.020 |
Why?
|
Ligands | 1 | 2015 | 3273 | 0.020 |
Why?
|
Blotting, Western | 1 | 2015 | 5020 | 0.020 |
Why?
|
Antibodies, Neutralizing | 1 | 2018 | 2010 | 0.020 |
Why?
|
Chronic Disease | 2 | 2017 | 9347 | 0.020 |
Why?
|
Cohort Studies | 3 | 2017 | 41649 | 0.020 |
Why?
|
Immunity | 1 | 1993 | 1002 | 0.020 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2018 | 1646 | 0.020 |
Why?
|
CD40 Ligand | 1 | 2009 | 528 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2018 | 10729 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 81514 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2014 | 20124 | 0.020 |
Why?
|
Liver | 1 | 2001 | 7562 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2017 | 3681 | 0.010 |
Why?
|
Survival Analysis | 1 | 2017 | 10070 | 0.010 |
Why?
|
Preoperative Care | 1 | 2014 | 2267 | 0.010 |
Why?
|
Monocytes | 1 | 2014 | 2595 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 2006 | 276 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2008 | 2014 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2019 | 11206 | 0.010 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2015 | 3513 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8733 | 0.010 |
Why?
|
Listeria monocytogenes | 1 | 2006 | 244 | 0.010 |
Why?
|
Contrast Media | 1 | 2017 | 5329 | 0.010 |
Why?
|
Disease Progression | 2 | 2014 | 13632 | 0.010 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2060 | 0.010 |
Why?
|
Interleukin-2 | 1 | 2010 | 1896 | 0.010 |
Why?
|
Brain Ischemia | 1 | 2016 | 3000 | 0.010 |
Why?
|
Risk Assessment | 2 | 2017 | 24282 | 0.010 |
Why?
|
Time Factors | 2 | 2017 | 40065 | 0.010 |
Why?
|
Epitopes | 1 | 2008 | 2523 | 0.010 |
Why?
|
Pancreas | 1 | 2008 | 1700 | 0.010 |
Why?
|
Organ Specificity | 1 | 2006 | 1965 | 0.010 |
Why?
|
Remission Induction | 1 | 2006 | 2411 | 0.010 |
Why?
|
Kinetics | 1 | 2008 | 6274 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11022 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2015 | 12768 | 0.010 |
Why?
|
Transforming Growth Factor beta | 1 | 2008 | 1995 | 0.010 |
Why?
|
Sirolimus | 1 | 2007 | 1545 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8041 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9525 | 0.010 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1789 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2009 | 6493 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2009 | 6499 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15398 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2009 | 5302 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22223 | 0.010 |
Why?
|
Inflammation | 1 | 2017 | 10850 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12056 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2010 | 12509 | 0.010 |
Why?
|
Prognosis | 1 | 2016 | 29922 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2009 | 12437 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18380 | 0.010 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3401 | 0.010 |
Why?
|
Recurrence | 1 | 2006 | 8501 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2014 | 39193 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2008 | 11641 | 0.010 |
Why?
|
Child | 2 | 1996 | 80564 | 0.010 |
Why?
|
Risk Factors | 1 | 2017 | 74840 | 0.010 |
Why?
|
Young Adult | 1 | 2016 | 59889 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2016 | 36532 | 0.000 |
Why?
|
Drug Therapy, Combination | 1 | 1994 | 6309 | 0.000 |
Why?
|
Adolescent | 1 | 2010 | 88835 | 0.000 |
Why?
|
Combined Modality Therapy | 1 | 1994 | 8529 | 0.000 |
Why?
|
United States | 1 | 2009 | 72903 | 0.000 |
Why?
|